Intranasal replicon vaccine establishes mucosal immunity and protects against H5N1 and H7N9 influenza
2026 · Nature Communications · 0 citations
https://doi.org/10.1038/s41467-025-64829-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Michael A. Davis is an academic researcher.
Click to start Chat